Login / Signup

Spanish consensus on the management of concomitant antiseizure medications when using cenobamate in adults with drug-resistant focal seizures.

Mar CarreñoAntonio Gil-NagelJosé M SerratosaManuel ToledoJuan Jesus Rodriguez-UrangaVicente Villanueva
Published in: Epilepsia open (2024)
Patients with epilepsy may continue to have seizures even after treatment with several different antiseizure medications (ASMs). Cenobamate is an ASM that can reduce seizures in these patients. In this study, six Spanish experts in epilepsy discussed the best way to use cenobamate in drug-resistant epilepsy. They provide practical guidance on when and how the dose of other ASMs might be adjusted to reduce side effects and optimize the use of cenobamate.
Keyphrases
  • drug resistant
  • multidrug resistant
  • acinetobacter baumannii
  • temporal lobe epilepsy
  • end stage renal disease
  • chronic kidney disease
  • peritoneal dialysis
  • prognostic factors
  • pseudomonas aeruginosa